Fiera Capital (Canada)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.6M Buy
506,284
+9,861
+2% +$535K 0.08% 165
2026
Q1
$31.2M Buy
496,423
+174,940
+54% +$14M 0.11% 155
2025
Q4
$30.7M Buy
321,483
+102,193
+47% +$10M 0.1% 158
2025
Q3
$21.4M Buy
+219,290
New +$22.7M 0.07% 161
2022
Q4
Sell
-5,550
Closed -$215K 511
2022
Q3
$215K Buy
+5,550
New +$223K ﹤0.01% 534

Other funds holding BSX

Fiera Capital (Canada)'s BSX Position: Q2 2026 in Review

Fiera Capital (Canada) increased its Boston Scientific (BSX) stake by 2% in Q2 2026, buying an estimated $535K and bringing the position to 506,284 shares worth $21.6M. The position accounts for 0.08% of the portfolio, ranked #165.

Fiera Capital (Canada) first reported a position in BSX in Q3 2022 and has held it in 5 quarters since. The position peaked at $31.2M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fiera Capital (Canada) held 506,284 shares of Boston Scientific worth $21.6M as of Q2 2026.
  • Fiera Capital (Canada) bought 9,861 Boston Scientific shares in Q2 2026, an estimated $535K.
  • Boston Scientific made up 0.08% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #165 holding.
  • Fiera Capital (Canada) first reported a position in Boston Scientific in Q3 2022 and has held it in 5 quarters since.
  • Fiera Capital (Canada)'s Boston Scientific position peaked at $31.2M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.